Patents

We operate an invention pipeline: conjecture, internal experimental validation, filing, then public disclosure. Every primitive we publish has a priority date locked with the USPTO before it leaves private research.

Foreign rights are preserved via the Patent Cooperation Treaty (PCT) window following each US provisional filing. The PCT window expires 12 months after the provisional priority date; until it files, foreign rights remain contingent on non-disclosure outside of NDA.

The following inventions have US provisional applications on file with the USPTO. Each is available for licensing under non-exclusive, exclusive, or field-of-use terms.

DeltaWrite

Systems and methods for persistent inference-time weight modification of pretrained neural networks via forward-only low-rank adapter construction. US provisional filed 2026-04-11 with the USPTO. PCT window open through 2027-04-11.

LRM v2

A novel transformer architecture designed to accept portable Knowledge Modules at runtime. In active build. Patent strategy following the DeltaWrite cadence; filing details to be published on priority date lock.

Additional primitives are in private research and have not been publicly disclosed. Their existence, character, and timelines are shared only under NDA.

This page is updated each time a new priority date is locked. If you are evaluating the lab for investment or licensing, ask for the pipeline briefing.

All filed inventions are available for licensing. Terms range from non-exclusive deployment licenses to exclusive, field-of-use arrangements with strategic partners. Replication kits, benchmark data, and technical deep-dives are shared under NDA.

Licensing conversations begin with a private briefing. Use the contact form on the home page or email the lab directly.

“Gargantua Labs”, “DeltaWrite”, “LRM v2”, and associated marks are claimed common-law trademarks of Gargantua Labs. Third-party names referenced on this site (Qwen, Llama, Mistral, and others) are the property of their respective owners and are used only for factual, comparative purposes.